MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2020-21)
- Udyam number
- UDYAM-MH-17-0001052
Agog Pharma Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹89.88 Cr
▼ 7% YoY
Net profit · FY 2024
₹8.67 Cr
Net margin 9.6%
EBITDA · FY 2024
₹12.98 Cr
EBITDA margin 14.4%
Authorised capital
₹3.15 Cr
Registered with MCA
Paid-up capital
₹3.15 Cr
Issued & subscribed
Open charges
₹12.5 Cr
Satisfied ₹13.48 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
88
Provident fund records
About Agog Pharma Limited
Data last updated:
Agog Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PLC059515. Its GSTIN is 27AABCA3911E1Z7 (Maharashtra).
The company has an authorised share capital of ₹3.15 Cr and a paid-up capital of ₹3.15 Cr. It was formerly known as Agog Pharma Private Limited. It is led by directors including Anil Kumar Anirudh Pandey (Whole-Time Director) and Aziz Abdulhamid Damani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.33 Sector II The Vasai Taluka Indl.Co – Op Estate Ltd Gaurai Pada Vasai(East), Mumbai, Maharashtra, India – 401208.
As per the financials filed for FY 2024, the company reported a revenue of ₹89.88 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹8.67 Cr (net margin 9.6%) and EBITDA of ₹12.98 Cr (EBITDA margin 14.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company has about 88 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.5 Cr and satisfied charges of ₹13.48 Cr on record. Court records list 8 cases involving the company, including 8 filed against it. The company has 1 deal on record (1 funding round), with disclosed funding of ₹15 Lakh; the latest was in October 2010. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Sydler Remedies Private Limited with revenue of ₹91.31 Cr. The company has 20 MSME Form 1 returns on record between 2014 and 2024, listing 1,419 overdue payments to 105 micro and small suppliers.
Agog Pharma Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0001052). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agogpharma.com.
Company Details of Agog Pharma Limited
CIN U24230MH1990PLC059515
Registration Number 059515
Incorporation Date 20 December 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0001052
CIN History of Agog Pharma Limited
Agog Pharma has one previous CIN (Corporate Identification Number): U24230MH1990PTC059515. The current CIN is U24230MH1990PLC059515, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1990PLC059515 | Current |
| U24230MH1990PTC059515 | Previous |
Key People
Anil Kumar Anirudh Pandey Whole-Time Director Aziz Abdulhamid Damani Director Shenaz Aziz Damani Director Recognitions & Rankings of Agog Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.33 Sector II The Vasai Taluka Indl.Co – Op Estate Ltd Gaurai Pada Vasai(East), Mumbai, Maharashtra, India – 401208
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Agog Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Agog Pharma Limited
The main business activity of Agog Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Agog Pharma Limited FY 2025 filings available
Agog Pharma Limited reported revenue of ₹89.88 Cr (down 7% YoY) for FY 2024.
Revenue · FY 2024
₹89.88 Cr ▼ 7%
Net profit · FY 2024
₹8.67 Cr margin 9.6%
EBITDA · FY 2024
₹12.98 Cr margin 14.4%
Compounded Annual Growth Rate (CAGR) of Agog Pharma Limited
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 9%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 5%
5 years · compounded
▲ 7%
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Agog Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.98 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.67 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Agog Pharma Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Agog Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Agog Pharma Limited
Agog Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aziz Abdulhamid Damani | Director | 20 Jun 2005 | 21 Years 4 Months | Current |
| Shenaz Aziz Damani | Director | 02 Jun 2006 | 20 Years 4 Months | Current |
| Anil Kumar Anirudh Pandey | Whole-Time Director | 30 Sep 2005 | 21 Years 0 Months | Current |
Peer Comparison of Agog Pharma Limited
Agog Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sydler Remedies Private Limited | ₹91.31 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Aurangabad, Maharashtra, India |
| S. A. Pharmachem Private Limited | ₹91.25 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Mumbai, Maharashtra, India |
| Jiden Formulations Private Limited | ₹90.8 Cr (FY 2025) | •••• | •••• | 308.0% | •••• | Vadodara, Gujarat, India |
| Coral Laboratories Limited Listed | ₹90.29 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Gorakh Nath Formulations Private Limited | ₹89.91 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Meerut, Uttar Pradesh, India |
| Agog Pharma Limited this company | ₹89.88 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Alcedo Pharmachem Private Limited | ₹89.55 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Hyderabad, Telangana, India |
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | •••• | •••• | 263.0% | •••• | New Delhi, Delhi, India |
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Andhra Pradesh, India |
| Sam Fine O Chem Limited | ₹89.46 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Rajkot, Gujarat, India |
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | •••• | •••• | -2.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Agog Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Agog Pharma Limited
Agog Pharma Limited is audited by S B S K & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S B S K & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Agog Pharma Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Agog Pharma Limited
Open charges
₹12.5 Cr
Satisfied charges
₹13.48 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2019 | Others | ₹12.5 Cr | Open |
| 26 Nov 2007 | State Bank of India | ₹9.9 Cr | Satisfied |
| 21 Aug 2003 | State Bank of India | ₹1.4 Cr | Satisfied |
| 21 Aug 2003 | State Bank of India | ₹1 Cr | Satisfied |
| 24 Feb 1999 | State Bank of India | ₹20 Lakh | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Agog Pharma Limited
Agog Pharma Limited has 1 deal on record (1 funding round), with disclosed funding of ₹15 Lakh; the latest was in October 2010.
Total deals
1
Funding round
1
Disclosed funding
₹15 Lakh
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2010 | Funding round | ₹15 Lakh | Investors: an individual |
Premium access
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Agog Pharma Limited
Agog Pharma Limited has 8 court cases on record: 8 filed against it. All cases are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Total cases
8
Filed against the company
8
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 6 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by Protocol Marine Services Private Limited | Disposed |
| Bombay High Court | Company petition | Filed against the company by Klenzaids Bioclean Devices Private Limited | Disposed |
| Bombay High Court | Company petition | Filed against the company by Klenzaids Contamination Controls Private Limited | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.PGA) | Filed against the company by an individual | Disposed |
| Bombay High Court | Company petition | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Agog Pharma Limited
Agog Pharma Limited has 20 MSME Form 1 returns on record between 2014 and 2024, listing 1,419 overdue payments to 105 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 105)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Kalapi Print Pack LLP | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Invochem Laboratory | •••• | •••• | •••• |
| Archk Pharma Co. | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 20 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Agog Pharma Limited
Agog Pharma Limited has a workforce of 88 employees as of Apr 03, 2024.
Employee count
88
Active EPFO establishments
1
Employee growth
1.15%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Agog Pharma Limited
Agog Pharma Limited has 6 board changes on record since 2005: 3 appointments and 3 cessations. The latest: Aziz Abdulhamid Damani ceased to be Director on 01 Apr 2010.
AGM
Agog Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Agog Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 12.50 Cr registered on 30 May 2019 with Charge ID 100269756 was modified on 03 Oct 2024.
Charges
A charge registered on 26 Nov 2007 via Charge ID 10085418 with State Bank Of India was fully satisfied on 10 Feb 2020.
Charges
A charge with Others amounted to Rs. 12.50 Cr with Charge ID 100269756 was registered on 30 May 2019.
Charges
A charge registered on 30 Dec 1993 via Charge ID 90186012 with Development Co-Op Bank Ltd. was fully satisfied on 11 Dec 2018.
Charges
A charge registered on 26 Dec 1992 via Charge ID 90189106 with Development Co-Op Bank Ltd. was fully satisfied on 11 Dec 2018.
Charges
A charge registered on 18 Mar 1998 via Charge ID 90186550 with The Bharat Co-Op. Bank Ltd. was fully satisfied on 08 Aug 2018.
Charges
A charge with State Bank Of India of Rs. 9.90 Cr registered on 26 Nov 2007 with Charge ID 10085418 was modified on 31 Mar 2017.
Ceased
Aziz Abdulhamid Damani ceased to be Director.
Ceased
Shenaz Aziz Damani ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 9.90 Cr with Charge ID 10085418 was registered on 26 Nov 2007.
17 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Agog Pharma Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Agog Pharma Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Agog Pharma Limited
Agog Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCA3911E1Z7 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Agog Pharma Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Agog Pharma Limited
Agog Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 December 1990 (36+ years old) and is registered under CIN U24230MH1990PLC059515.
Agog Pharma reported revenue of ₹89.88 Cr for FY 2024 (down 7% YoY).
Agog Pharma has 3 current directors:
- Anil Kumar Anirudh Pandey - Whole-Time Director
- Aziz Abdulhamid Damani - Director
- Shenaz Aziz Damani - Director
Agog Pharma reported a net profit of ₹8.67 Cr (net margin 9.6%) and EBITDA of ₹12.98 Cr (EBITDA margin 14.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Agog Pharma is 9% over three years and 9% over five years. In the latest year (FY 2024) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Agog Pharma is 27AABCA3911E1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Agog Pharma is U24230MH1990PLC059515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Agog Pharma has 8 court cases on record: 8 filed against it. Most are in the high courts.
Agog Pharma was incorporated on 20 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Agog Pharma has 1 deal on record (1 funding round), with disclosed funding of ₹15 Lakh; the latest was in October 2010.
The peers of Agog Pharma by revenue are Sydler Remedies Private Limited, S. A. Pharmachem Private Limited, Jiden Formulations Private Limited, Coral Laboratories Limited, Gorakh Nath Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Aziz Abdulhamid Damani ceased to be Director on 01 Apr 2010. Shenaz Aziz Damani ceased to be Director on 01 Jan 2009. Shenaz Aziz Damani was appointed as Director on 02 Jun 2006. Agog Pharma has 6 board changes on record in total.